Newsroom | 2257 results

DALLAS--(BUSINESS WIRE)--Concentra Group Holdings Parent, Inc. (“Concentra”, the “Company”, “we”, “us”, or “our”) (NYSE: CON), the nation’s largest provider of occupational health services by number of locations, today announced results for the second quarter ended June 30, 2026, declaration of a cash dividend, and raised its full-year 2026 guidance. The quarter included revenue growth of 10.0%, net income attributable to the Company growth of 46.5%, Adjusted EBITDA growth of 22.5% and a net le...

HOUSTON--(BUSINESS WIRE)--IPS HEART, Inc., a biopharmaceutical company pioneering induced pluripotent stem cell (iPSC)-derived cell replacement therapies, announced that the FDA has granted Rare Pediatric Drug Designation for ISX9-CPC, for the treatment of cardiomyopathies associated with dystrophinopathies. Redefining the Therapeutic Paradigm: Generating New Human Muscle Duchenne muscular dystrophy (DMD) leads to progressive skeletal muscle loss, severe cardiac fibrosis, and premature death fr...

HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services (“IIP”), today reported results for the three and six months ended June 30, 2026. Total net revenue of $214.1 million for the second quarter ended June 30, 2026 (“Q2 2026”), an 8.5% increase over the second quarter ended June 30, 2025 (“Q2 2025”). Net income attributable to USPH...

TORONTO--(BUSINESS WIRE)--NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), operates one of Canada’s largest networks of community-based, multidisciplinary medical facilities focused on the assessment and treatment of chronic pain, musculoskeletal/back pain, sports medicine and other pain medical services, today announced that it will release its interim financial results for the three and six months ended June 30, 2026 before markets open on Thursday, August 13, 2026. Investors and...

NASHVILLE, Tenn.--(BUSINESS WIRE)--HealthTrust Performance Group™ (HealthTrust) hosted its third annual 340B Summit in Denver from July 22-23, 2026, to help members navigate the evolving 340B Drug Pricing Program, in its efforts to make healthcare missions possible. With increased compliance demands for covered entities, ongoing legal challenges and heightened scrutiny, HealthTrust members explored issues spanning legislation, drug pricing and operations that directly impact 340B program effect...

FORT WORTH, Texas--(BUSINESS WIRE)--Creative Solutions in Healthcare (CSNHC) has renewed its partnership with Quality Rehab Management (QRM), a Focal Point Care company, for an additional three-year term, extending a successful collaboration that has supported CSNHC’s in-house therapy model, strengthened facility-level performance and enhanced resident outcomes throughout its skilled nursing communities. The renewed agreement reflects CSNHC’s confidence in the value and support QRM delivers. Th...

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced financial results for the second quarter ended June 30, 2026. Second Quarter 2026 Results Revenue totaled $865.8 million, which was approximately flat compared with the second quarter of 2025. As described on page 2, total revenue growth in the second quarter was 2.8%1 after normalizing for prior period supplemental payment program revenue in each of the respective quarte...

BOSTON--(BUSINESS WIRE)--REEV launches its pivotal clinical study of the DREEVEN robotic knee brace in post-stroke mobility in clinical and home settings....

STAMFORD, Conn.--(BUSINESS WIRE)--Neuvotion, Inc. is an early-stage medical device company developing an AI-guided neuromodulation platform to accelerate recovery after neurological events such as stroke and spinal cord injury. Its Brain-Body Interface (BBI) portfolio integrates wearable high-resolution muscle stimulation, spinal neuromodulation, and minimally invasive brain-computer interface (BCI) technologies to restore movement and sensation. By combining AI, intention-driven neurostimulati...

SAN FRANCISCO--(BUSINESS WIRE)--SPRY Therapeutics today introduced its clinical advisory board: nine practicing clinic leaders, joined by the company's two core leaders including founder. The group meets frequently, working directly with the product team on AI-assisted clinical workflows, with one goal in mind: helping practices grow while keeping care personal. Board members were selected for their hands-on experience running outpatient physical, occupational, and speech therapy practices. The...